Preoperative Staging of Breast Câncer
DOI:
https://doi.org/10.32635/2176-9745.RBC.1999v45n3.2780Keywords:
Breast Cancer, Screening, PreoperativeAbstract
Preoperative screening for metastases (M) in patients with operable breast câncer (Ca) is a controversial question. The objective of the present study was to evaluate the frequency of hidden M, synchronic bilateral câncer and the monetary cost of this screening in situations in which surgery represents the initial treatment option for these patients. On this basis, we conducted a retrospective study (60 months) of 454 patients with operable breast cancer registered at the National Cancer Institute, Brazil, in which we analyzed clinical staging. The patients were submitted to physical examination, mammography, bone scintgraphy complemented with radiography (Rx) in cases of hyperfixation of the radiotracer, chest Rx and hepatic ultrasonography (USG), this last exam being performed only on 260 (57,3%) patients. We did not identify in the medical records any clinical or operational reasons that would have justified not performing hepatic USG in all patients. Screening for subclinical synchronous bilateral cancer in the contralateral breast was negative in all patients (0/454). The frequency of hidden metastasis was 2% (9/454). Bone metastasis were detected in 1,5% of patients (7/454), pulmonary M in 2/454 and hepatic M in 1/260, all with the same percentage of0,4%. The cost of the preoperative screening for hidden metastasis and synchronous bilateral câncer in the 454 patients was US$ 131,020.00. Considering that the number of metastasis identified was equal to 10, in 9 patients (one patient had synchronous liver and bone metastasis), each diagnosed metastasis cost US$ 13,102.00 (US$ 131,020/10). We conclude that the cost of preoperative screening for metastasis in patients with operable breast câncer is high, with low effectiveness in identifying hidden metastasis in only a reduced number (9) of asymptomatic patients.
Downloads
References
BRAR, H.S.; SISLEY, J.F; JOHNSON, R. H. - Value of preoperative bone and liver scans and alkaline phosphate in the evaluation of breast câncer patients. Am J Surg 165:221-224, 1993. DOI: https://doi.org/10.1016/S0002-9610(05)80512-4
KINNE, D.W. - Staging and follow-up of breast câncer patients. Câncer 67: 1196-1198, 1991. DOI: https://doi.org/10.1002/1097-0142(19910215)67:4+<1196::AID-CNCR2820671515>3.0.CO;2-4
CHARKES, N.D.; MALMUD, L.S; CASWELL, T. et al. – Preoperative bone scans: use in women with early breast câncer. JAMA 233(6):516-518, 1975. DOI: https://doi.org/10.1001/jama.233.6.516
CITRIN, D.L; BESSENT, R.G; GREIG, W.R. et al. -The application of 99Tcm phosphate bone scan to the study of breast câncer. Br J Surg 62:201-204, 1975. DOI: https://doi.org/10.1002/bjs.1800620307
GALASKO, C.S.B. - The significance of occult skeletal metastases detected by Skel- et al Scintigraphy, in patients with otherwise apparent “early” mammary carcinoma. Br J Surg 62:694-696, 1975. DOI: https://doi.org/10.1002/bjs.1800620906
BAKER, R.R; HOLMES, E.R.; ALDERSON, RO. et al. - An evaluation of bone scans as screening procedures for occult metastases in primary breast câncer. Ann Surg 86(3):363-368, 1977. DOI: https://doi.org/10.1097/00000658-197709000-00014
CIATTO, S.; PACINI, R; BRAVETTI, P. et al. - Staging breast câncer screening for occult metastases. Tumori 71:339-344, 1985. DOI: https://doi.org/10.1177/030089168507100404
CIATTO, S.; PACINI, R; AZZINI, V. et al. - Preoperative staging of primary breast câncer - a multicentric study. Câncer 61:1036-1040, 1988. DOI: https://doi.org/10.1002/1097-0142(19880301)61:5<1038::AID-CNCR2820610530>3.0.CO;2-Z
EORREST, A.P.M; CANT, E.L.M; ROBERTS, M.M. et al: Is the investigation of breast câncer for occult metastatic Worth while ? BrJ Surg 66:749-751, 1979. DOI: https://doi.org/10.1002/bjs.1800661019
SCANLON, E.F.; OVIEDO, M.A.; CUNNINGHAM, M.P. et al – Preoperative and follow-up procedures on patients with breast câncer. Câncer 46:977-979, 1980. DOI: https://doi.org/10.1002/1097-0142(19800815)46:4+<977::AID-CNCR2820461320>3.0.CO;2-0
WILSON, G.S.; RICH, M.A.; BRENNAN, M.J. - Evaluation of bone scan in preoperative clinical staging of breast câncer. Arch Surg 115:415-419, 1980. DOI: https://doi.org/10.1001/archsurg.1980.01380040043007
MOSKOVIC, E; PARSONS, C; BAUM, M. - Chest radiography in the management of breast câncer. Br J Radiol 65:30-32, 1992. DOI: https://doi.org/10.1259/0007-1285-65-769-30
BERNSTEIN, J.L.; THOMPSON, W.D.; RISCH, N.; HOLFORD, T.R. - Risk factors predicting the incidence of second primary breast câncer among women diagnosed with a first primary breast câncer. Am J Epidemiol 136:925-936, 1992 a. DOI: https://doi.org/10.1093/oxfordjournals.aje.a116565
GADELHA, M.I.P; SALTZ, E; REZENDE, M.C.R.; PINHEIRO, L.R. - Câncer: um problema de saúde pública no Brasil. IBM 63(ll):38-46, 1992.
HAAGENSEN, C.D. - Enfermedades de la mama, Buenos Aires: Médica Panamericana, 3ª ed., 893-905, 1987.
GRAHAM, M.D.; YELLAND, A.; PEACOCK, J. - Bilateral carcinoma of the breast. Eur J Surg Oncol 19(3):259-264, 1993.
GERBER, E.H.; GOODREAU, J.J.; KIRCHNER, R; FOUTY, W. - Efficacy of preoperative and postoperative bone scanning in the management of breast carcinoma. N Engl J Med 297(11):300-303, 1977. DOI: https://doi.org/10.1056/NEJM197708112970603
DAVIES, C.J.; GRIFFITHS, P.A.; PRESTON, B.J. et al. - Staging breast cancer: role of bone scanning. Br Med J 2:603-605, 1977. DOI: https://doi.org/10.1136/bmj.2.6087.603
MONYPENNY, I.J.; GRIVE, R.J.; HOWELL, A. et al - The value of serial bone scanning in operable breast câncer. Br J Surg 71:466-468, 1984. DOI: https://doi.org/10.1002/bjs.1800710622
VESTERGAARD, A.; HERRSTEDT, J.; THOMSEN, H. et al. The value of yearly chest X-ray in patients with stage 1 breast câncer. Eur J Câncer Clin Oncol 25(4): 687- DOI: https://doi.org/10.1016/0277-5379(89)90205-8
, 1989.
